ArticleFrontiers in microbiology2025

Rivaroxaban alleviates hepatic sinusoidal obstruction syndrome in mice by modulating the gut microbiota and inhibiting the PI3K/Akt signaling pathway.

Wencheng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.